Industry News
Share price increase follows Biotron's HIV success
Canberra biotech Biotron has announced that its lead anti-HIV compound, BIT009 has shown inhibition of HIV-1 replication in infected human cells. [ + ]
New members for Anadis' advisory panel
One local and one international scientist have joined the ranks of natural biopharmaceutical developer Anadis. [ + ]
$20 million Tasmania bio-informatics centre
A $20 million Centre of Excellence in bio-informatics has been created for Tasmania under the Federal Government's $40 million Intelligent Island program.
[ + ]Portland Orthopaedics expands
Medical device company Portland Orthopaedics has expanded into a larger Sydney-based facility to develop and manufacture its new style of hip and knee replacement joints. [ + ]
Tocovite claims its technology delivers
Melbourne-based company Tocovite claims an absorption system that it has developed could improve drug delivery through the skin. [ + ]
CRC students digging ethical minefields
Last week's Cooperative Research Centre Association conference revealed that ethical issues and public consultation are pertinent to the technological developments currently undertaken by Australian CRCs. [ + ]
Prima's investment to assist cancer research
An investment in a novel monoclonal antibody with anti-cancer properties was announced today by Prima BioMed. [ + ]
IDT buys clinical trials research unit
Contract research group Institute of Drug Technology Australia (ASX: IDT) has purchased a clinical trials research unit in a deal the company said will bolster its annual revenue by 20 per cent. [ + ]
ResMed chases cardiac treatment market
Sleep disorder device company ResMed is on track to market its AutoSet CS device for the treatment of patients of cardiac heart failure. [ + ]
AusBiotech calls for action on R&D Start
Peak biotechnology industry organisation AusBiotech will urge the Federal government to announce the future of the R&D Start scheme on July 1. [ + ]
Science Industry Australia - NSW branch meeting
The next meeting of the NSW Chapter of Science Industry Australia will be held on June 6 at the Silverwater Club.
[ + ]US man first to receive Sirtex cancer treatment
Anti-cancer treatment SIR-Spheres, designed by Sydney-based company Sirtex, has been used on a patient for the first time since it received US Food and Drug Administration (FDA) approval in March this year. [ + ]
Diabetes research offensive launched
A research and development agreement with the aim of finding an effective treatment for type II diabetes has been signed in Melbourne. [ + ]
Melbourne researchers discover heart attack gene link
Australian researchers have determined three genetic loci which are linked to heart attacks. [ + ]
Industry-minded CRCs awarded
Four Cooperative Research Centres (CRCs) have been honoured for their effective collaborations with industry. [ + ]
